TherapeuticsMD (TXMD) Inventory Average (2012 - 2022)

TherapeuticsMD (TXMD) has reported Inventory Average for 10 consecutive years, with $6.4 million the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Inventory Average fell 13.96% year-over-year to $6.4 million; the trailing twelve-month figure through Sep 2022 stood at $6.4 million (down 13.96% YoY), and the FY2021 full-year result was $7.8 million, down 21.35% from the prior year.
• Inventory Average slipped to $6.4 million in Q3 2022 per TXMD's latest filing, from $7.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $13.2 million in Q1 2020 and bottomed at $1.6 million in Q1 2018.
• Historically, Inventory Average has averaged $7.1 million across 5 years, with a median of $7.5 million in 2021.
• The sharpest annual moves came in 2019 and 2021: Inventory Average surged 323.3% in 2019, then plunged 42.05% in 2021.
• Over 5 years, Inventory Average stood at $2.8 million in 2018, then surged by 296.63% to $11.2 million in 2019, then declined by 19.95% to $9.0 million in 2020, then retreated by 16.41% to $7.5 million in 2021, then dropped by 14.24% to $6.4 million in 2022.
• According to Business Quant data, Inventory Average over the past three periods registered $6.4 million, $7.6 million, and $8.3 million for Q3 2022, Q2 2022, and Q1 2022 respectively.